focus -WSS

focus

author：comprehensive 2025-09-27 23:52:59 - browse：144

Sorrento Therapeutics — ARIANA DREHSLER/AFP via Getty Images

SAN DIEGO — U.S. legislation that seeks to restrict American biotechs from working with certain Chinese firms and suppliers is for now just that — a proposal, not a law. But the looming bill’s impact was clearly visible at this year’s meeting of the industry’s largest trade group.

A number of biotech companies in attendance at the meeting of the Biotechnology Innovation Organization told STAT they’re actively looking to strike deals with U.S.-based drug manufacturers rather than companies named in the legislation, even though doing so will be more costly. An executive at a U.S.-based contract development and manufacturing organization, or CDMO, who spoke on condition of anonymity, said that “month to month, new business has gone through the roof.”

Meanwhile, some Chinese suppliers not named in the bill are paradoxically drawing increased interest from biotechs — while hearing from some customers worried those manufacturers could be blacklisted in the future.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Roche’s Alnylam deal shows drug firms interested in heart drugs

leisure time

hotspot

WSS

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Truvian presents data for its desktop blood

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Wildfire smoke exposes gaps in outdoor worker protections

'Weather

The high cost of giving birth even with insurance

What to watch for from Zogenix and Amicus clinical trials

In Memoriam: Notable people who died in 2023

UHS says company favors patients whose insurance pays more

New air purifier tech could be key to improving indoor air quality

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Tori Bowie and the unacceptable rates of Black maternal death

Device maker Teleflex to acquire urology company for $600M

focus

Device maker Teleflex to acquire urology company for $600M

Many immigrants are left out of maternal health programs

Search called off for baby washed away in Pennsylvania flash flood

Doctors in states that ban abortion can still help patients

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

HCA says smaller share of spending going to labor

leisure time

hotspot

entertainment

Wikipedia